CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing novel targeted medicines primarily for cancer treatment, today announced that the Company’s presentation time has moved to 8:40 a.m. local time (2:40 a.m. Eastern Daylight Time) on May 15, 2007 at the Acumen Biofin Rodman & Renshaw 4th Annual Global Healthcare Conference, which is being
